Scienze dell'Interazione anno 2012 n.1-2 - Scuola di ...

77
Scienze dell’Interazione, n. 1-2, 2012
Poma L., Bianchi di Castelbianco F. (2006) Giù le mani dai bambini. Iperattività,
depressione e altre «moderne» malattie: la salute dei minori e il marketing del
farmaco. Ma.Gi. Editore.
Poma L. (2008) Riepilogo delle istanze di modifica alle raccomandazioni, linee
guida e protocolli diagn.- ter. dell’ISS sul “progetto ADHD”.
http://www.giulemanidaibambini.org/documentiscientifici/glm_documentiscientifici_
38.pdf
Poulton A. (2005) Growth on stimulant medication; clarifying the confusion: a
review. Archives of Disease in Childhood;90:801–806.
Puig-Antich J.(1980a), Affect. disorders in childhood, A review and perspective,
Psych.Clinics of N. America, 3:403-423
Rao J.K., Julius J.R., Breen T..J., Blethen S.L. (1998) "Response to growth
hormone inattention deficit hyperactivity disorder: effects of metilfenidato and
pemoline therapy". Pediatrics. Aug;102(2 Pt 3):497-500.
Rapoport J., Buchsbaum M., Zahn T., Weingartner H., Ludlow C., Mikkelsen E.
(1978) Dextroamphetamine: cognitive and behavioral effects on normal prepubertal
boys. J. of Americ. Academy of Child and Adolesc. Psychiatry,190, 560-3.
Rapoport J., Buchsbaum M., Weingartner H., Zahn T., Ludlow C., Mikkelsen F.
(1980) Dextroamphetamine: ist cognitive and behave. effects in normal amd
hyperactive boys and normal man. Arch. of General Psych., 37:933-43.
Rapoport J.L., Inoff-Germain G. (2002) Responses to methylphenidate in Attention-
Deficit/Hyperactivity Disorder and normal children: update, J Atten Disord. 6 Suppl
1:57-60.
Reid R., Maag .J, Wasa S.. (1993) ADHD as a disability category: a critique.
Exceptional Children, 60:198-214.
Ross, D.M., Ross,S.A.(1982) Hyperactivity:Current, reser. and theory,
N.York:Wiley & Sons.
Rutter M. (1983) Issues and prospects in developmental neuropsychiatry. In Rutter
M. (ed) Developmental Neuropsychiatry. New York: Guilford Press.
SINPIA, Societa’ Italiana Di Neuropsichiatria Dell’infanzia E Dell’adolescenza
(2002) Linee guida per la riabilitazione dei bambini affetti da paralisi cerebrale
infantile, 2005-2006.
Safer, D.J. (1973) A familiar factor in minimal brain dysfunction. Behav. Genet., 3,
175-186.
Szasz, T., (2001) Pharmacracy: Medicine and Politics in America, Praeger, XXIV.
Selye, H. (1974) Stress Without Distress. Philadelphia: J.B. Lippincott.
Shaywitz B., Fletcher J., Shaywitz S. (1995) Definining and classifying learning
disabilities and attention deficit hyperactivity disorder. J of Child Neurology,
10:S50-S57.
Sherman D.K., Iacono W.G., McGue, M.K. (1997) Attention-deficit hyperactivity
disorder dimensions: A twin study of inattention and impulsivity-hyperactivity. J. of
the Amer. Academy of Child and Adolescent Psychiatry, 36(6), 745-753.
Shields J. (1962) Monozyg. twins,brought up apart and brought up together, Oxford
Univ. Pr.
Smith L. (2002) Ritalin prescript. takes life of 14-year-old,
www.rense.com/general25/14.htm.
Swanson J.M. et al. (1998) Association of the dopamine receptor D4 (DRD4) gene
with a refinedphenotype of attention deficit hyperactivity disorder (ADHD): a familybased
approach. Mol Psychiatry, 3:38-41.
Swanson, J.M.; W. Nolan, W.E. Pelham (1992).”The SNAP-IV Rating Scale”, www.
Adhd.net. Retrieved 2009-02-16.
Stolzer, J. (2005). ADHD in Amer.: A bioecological anal. Et.H. Psych. and Psyc.,
7(1), 65-75.